The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma by Ozyerli-Goknar, E, Sur-Erdem, I, Seker, F, Cingöz, A, Kayabolen, A, Kahya, Z, Uyulur, F, Gezen, M, Tolay, N, Erman, B, Gönen, M, Dunford, J, Oppermann, U, Bagci-Onder, T

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival by Ozyerli-Goknar, E, Kala, EY, Aksu, AC, Bulut, I, Cingöz, A, Nizamuddin, S, Biniossek, M, Seker-Polat, F, Morova, T, Aztekin, C, Kung, SHY, Syed, H, Tuncbag, N, Gönen, M, Philpott, M, Cribbs, AP, Acilan, C, Lack, NA, Onder, TT, Timmers, HTM, Bagci-Onder, T